Stenotrophomonas maltophilia - The most worrisome threat among unusual non-fermentative gram-negative bacilli from hospitalized patients: A prospective multicenter study

Journal of Infection

Volumn 64, Issue 4, 2012, Pages 391-398

  Fihman, Vincent ^a   Le Monnier, Alban ^b   Corvec, Stephane ^c,d   Jaureguy, Francoise ^e,f   Tankovic, Jacques ^g,h   Jacquier, Hervé ^i,j   Carbonnelle, Etienne ^j,k   Bille, Emmanuelle ^l   Illiaquer, Marina ^c,d   Cattoir, Vincent ^m   Zahar, Jean Ralph ^l  

^a HÔPITAL LOUIS MOURIER   (France)

^b CENTRE HOSPITALIER DE VERSAILLES   (France)

^c NANTES UNIVERSITY HOSPITAL   (France)

^d UNIVERSITÉ DE NANTES   (France)

^e AVICENNE HOSPITAL   (France)

^f UNIVERSITÉ PARIS 13   (France)

^g HÔPITAL SAINT ANTOINE   (France)

^h SORBONNE UNIVERSITÉ   (France)

ⁱ HÔPITAL LARIBOISIÈRE   (France)

^j UNIVERSITÉ PARIS DESCARTES   (France)

^k HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^l HÔPITAL NECKER ENFANTS MALADES   (France)

^m CHU CÔTE DE NACRE   (France)

more..

Author keywords

Adequate antimicrobial treatment; Gram negative aerobic rods; Infection; Outcome; Risk factor

Indexed keywords

AMINOGLYCOSIDE; ANTIBIOTIC AGENT; CARBAPENEM; CEPHALOSPORIN; PENICILLINASE; QUINOLONE DERIVATIVE;

ACHROMOBACTER; ADULT; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIUM ISOLATION; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG USE; FEMALE; HOSPITAL PATIENT; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; STENOTROPHOMONAS MALTOPHILIA; URINARY CATHETER;

AGED; ANTI-BACTERIAL AGENTS; CARBAPENEMS; COHORT STUDIES; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; FEMALE; FERMENTATION; FRANCE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HOSPITALS, TEACHING; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; STENOTROPHOMONAS MALTOPHILIA; TREATMENT OUTCOME;

EID: 84858443801     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2012.01.001     Document Type: Article

References (30)

1. Gaynes R., Edwards J.R. Overview of nosocomial infections caused by gram-negative bacilli. Clin Infect Dis 2005, 41(6):848-854.
2. Kerr K.G., Snelling A.M. Pseudomonas aeruginosa: a formidable and ever-present adversary. J Hosp Infect 2009, 73(4):338-344.
3. Peleg A.Y., Seifert H., Paterson D.L. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 2008, 21(3):538-582.
4. Davies J.C., Rubin B.K. Emerging and unusual gram-negative infections in cystic fibrosis. Semin Respir Crit Care Med 2007, 28(3):312-321.
5. Vidal F., Mensa J., Almela M., Olona M., Martinez J.A., Marco F., et al. Bacteraemia in adults due to glucose non-fermentative Gram-negative bacilli other than. Paeruginosa Qjm 2003, 96(3):227-234.
6. Enoch D.A., Birkett C.I., Ludlam H.A. Non-fermentative Gram-negative bacteria. Int J Antimicrob Agents 2007, 29(Suppl. 3):S33-S41.
7. Rolston K.V., Kontoyiannis D.P., Yadegarynia D., Raad Nonfermentative Gram-negative bacilli in cancer patients: increasing frequency of infection and antimicrobial susceptibility of clinical isolates to fluoroquinolones. Diagn Microbiol Infect Dis 2005, 51(3):215-218.
8. Cervia J.S., Ortolano G.A., Canonica F.P. Hospital tap water as a source of Stenotrophomonas maltophilia infection. Clin Infect Dis 2008, 46(9):1485-1487.
9. Bezanson G.S., MacInnis R., Potter G., Hughes T. Presence and potential for horizontal transfer of antibiotic resistance in oxidase-positive bacteria populating raw salad vegetables. Int J Food Microbiol 2008, 127(1-2):37-42.
10. Higgins C.S., Murtough S.M., Williamson E., Hiom S.J., Payne D.J., Russell A.D., et al. Resistance to antibiotics and biocides among non-fermenting Gram-negative bacteria. Clin Microbiol Infect 2001, 7(6):308-315.
11. Zavascki A.P., Carvalhaes C.G., Picao R.C., Gales A.C. Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: resistance mechanisms and implications for therapy. Expert Rev Anti Infect Ther 2010, 8(1):71-93.
12. McGowan J.E. Resistance in nonfermenting gram-negative bacteria: multidrug resistance to the maximum. Am J Med 2006, 119(6 Suppl. 1):S29-S36. [discussion S62-70].
13. Jacquier H., Carbonnelle E., Corvec S., Illiaquer M., Le Monnier A., Bille E., et al. Revisited distribution of nonfermenting Gram-negative bacilli clinical isolates. Eur J Clin Microbiol Infect Dis 2011.
14. Bonnet R., Cavallo J.D., Chardon H., Chidiac C., Courvalin P., Dabernat H., et al. Recommendations of antibiogram committee 2009, Société Française de Microbiologie, Paris, pp. 50.
15. Horan T.C., Andrus M., Dudeck M.A. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008, 36(5):309-332.
16. Cheong H.S., Kang C.I., Wi Y.M., Ko K.S., Chung D.R., Lee N.Y., et al. Inappropriate initial antimicrobial therapy as a risk factor for mortality in patients with community-onset Pseudomonas aeruginosa bacteraemia. Eur J Clin Microbiol Infect Dis 2008, 27(12):1219-1225.
17. Kang C.I., Kim S.H., Kim H.B., Park S.W., Choe Y.J., Oh M.D., et al. Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome. Clin Infect Dis 2003, 37(6):745-751.
18. Apisarnthanarak A., Mayfield J.L., Garison T., McLendon P.M., DiPersio J.F., Fraser V.J., et al. Risk factors for Stenotrophomonas maltophilia bacteremia in oncology patients: a case-control study. Infect Control Hosp Epidemiol 2003, 24(4):269-274.
19. Ryan M.P., Adley C.C. Sphingomonas paucimobilis: a persistent gram-negative nosocomial infectious organism. J Hosp Infect 2010, 75(3):153-157.
20. Ryan M.P., Pembroke J.T., Adley C.C. Ralstonia pickettii: a persistent gram-negative nosocomial infectious organism. J Hosp Infect 2006, 62(3):278-284.
21. Friedman N.D., Kaye K.S., Stout J.E., McGarry S.A., Trivette S.L., Briggs J.P., et al. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 2002, 137(10):791-797.
22. Harbarth S., Garbino J., Pugin J., Romand J.A., Lew D., Pittet D. Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am J Med 2003, 115(7):529-535.
23. Tumbarello M., Sali M., Trecarichi E.M., Leone F., Rossi M., Fiori B., et al. Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy. Antimicrob Agents Chemother 2008, 52(9):3244-3252.
24. Chaubey V.P., Pitout J.D., Dalton B., Ross T., Church D.L., Gregson D.B., et al. Clinical outcome of empiric antimicrobial therapy of bacteremia due to extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae. BMC Res Notes 2010, 3:116.
25. Marschall J., Agniel D., Fraser V.J., Doherty J., Warren D.K. Gram-negative bacteraemia in non-ICU patients: factors associated with inadequate antibiotic therapy and impact on outcomes. J Antimicrob Chemother 2008, 61(6):1376-1383.
26. del Toro M.D., Rodriguez-Bano J., Herrero M., Rivero A., Garcia-Ordonez M.A., Corzo J., et al. Clinical epidemiology of Stenotrophomonas maltophilia colonization and infection: a multicenter study. Medicine (Baltimore) 2002, 81(3):228-239.
27. Falagas M.E., Kastoris A.C., Vouloumanou E.K., Rafailidis P.I., Kapaskelis A.M., Dimopoulos G. Attributable mortality of Stenotrophomonas maltophilia infections: a systematic review of the literature. Future Microbiol 2009, 4(9):1103-1109.
28. Pitout J.D. Infections with extended-spectrum beta-lactamase-producing Enterobacteriaceae: changing epidemiology and drug treatment choices. Drugs 2010, 70(3):313-333.
29. Rodriguez-Bano J., Navarro M.D., Romero L., Muniain M.A., de Cueto M., Rios M.J., et al. Bacteremia due to extended-spectrum beta -lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge. Clin Infect Dis 2006, 43(11):1407-1414.
30. Tumbarello M., Sanguinetti M., Montuori E., Trecarichi E.M., Posteraro B., Fiori B., et al. Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment. Antimicrob Agents Chemother 2007, 51(6):1987-1994.